Sandy Spring Bank Armata Pharmaceuticals, Inc. Transaction History

Sandy Spring Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.96 - $5.86 $3,202 - $6,340	-1,082 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$3.89 - $4.87 $2,765 - $3,462	711 Added 191.64%	1,082 $4,000
Q1 2021 May 03, 2021	SELL	$3.02 - $6.33 $1,899 - $3,981	-629 Reduced 62.9%	371 $2,000
Q4 2020 Feb 03, 2021	BUY	$2.65 - $3.94 $795 - $1,182	300 Added 42.86%	1,000 $3,000
Q3 2020 Nov 09, 2020	BUY	$2.96 - $4.04 $296 - $404	100 Added 16.67%	700 $2,000

Q2 2020 Aug 12, 2020	BUY	$2.98 - $4.2 $298 - $420	100 Added 20.0%	600 $2,000
Q1 2020 May 01, 2020	BUY	$2.58 - $4.85 $1,290 - $2,425	500 New	500 $2,000

1.42M

200

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $96.5M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.